Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atrial Substrate Modification With Aggressive Blood Pressure Lowering to Prevent AF
NCT00438113Phase 4Completed
- Sponsor
- Nova Scotia Health
- Start
- Dec 2009
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quinapril, hydrochlorothiazide, atenolol, amlodipine, terazosin in Atrial fibrillation (AFib), sponsored by Nova Scotia Health. Started Dec 2009; status: completed.
02
Drugs
quinaprilhydrochlorothiazideatenololamlodipineterazosin
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00438113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00438113.